A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells

NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen =  1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica De Castro, Erika Stefàno, Erik De Luca, Antonella Muscella, Santo Marsigliante, Michele Benedetti, Francesco Paolo Fanizzi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2022/8932137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565493987278848
author Federica De Castro
Erika Stefàno
Erik De Luca
Antonella Muscella
Santo Marsigliante
Michele Benedetti
Francesco Paolo Fanizzi
author_facet Federica De Castro
Erika Stefàno
Erik De Luca
Antonella Muscella
Santo Marsigliante
Michele Benedetti
Francesco Paolo Fanizzi
author_sort Federica De Castro
collection DOAJ
description NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen =  1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity against eight human cancer cell lines. Pt-EtOMeSOphen showed higher cytotoxic effects than cisplatin in most of the cancer cell lines and in particular against the neuroblastoma cell line (SH-SY5Y). In this study, the mechanism of action of Pt-EtOMeSOphen on SH-SY5Y cells was investigated using 1H NMR-based metabolomics and compared with cisplatin. The observed time response of SH-SY5Y cells under treatment revealed a faster action of Pt-EtOMeSOphen compared with cisplatin, with a response already observed after six hours of exposure, suggesting a cytosolic target. NMR-based metabolomics demonstrated a peculiar alteration of the glutathione metabolism pathway and the diacylglycerol expression.
format Article
id doaj-art-20b281fd673e49f39730019a234fa4d7
institution Kabale University
issn 1687-479X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-20b281fd673e49f39730019a234fa4d72025-02-03T01:07:22ZengWileyBioinorganic Chemistry and Applications1687-479X2022-01-01202210.1155/2022/8932137A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer CellsFederica De Castro0Erika Stefàno1Erik De Luca2Antonella Muscella3Santo Marsigliante4Michele Benedetti5Francesco Paolo Fanizzi6Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen =  1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity against eight human cancer cell lines. Pt-EtOMeSOphen showed higher cytotoxic effects than cisplatin in most of the cancer cell lines and in particular against the neuroblastoma cell line (SH-SY5Y). In this study, the mechanism of action of Pt-EtOMeSOphen on SH-SY5Y cells was investigated using 1H NMR-based metabolomics and compared with cisplatin. The observed time response of SH-SY5Y cells under treatment revealed a faster action of Pt-EtOMeSOphen compared with cisplatin, with a response already observed after six hours of exposure, suggesting a cytosolic target. NMR-based metabolomics demonstrated a peculiar alteration of the glutathione metabolism pathway and the diacylglycerol expression.http://dx.doi.org/10.1155/2022/8932137
spellingShingle Federica De Castro
Erika Stefàno
Erik De Luca
Antonella Muscella
Santo Marsigliante
Michele Benedetti
Francesco Paolo Fanizzi
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
Bioinorganic Chemistry and Applications
title A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
title_full A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
title_fullStr A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
title_full_unstemmed A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
title_short A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
title_sort nmr based metabolomic approach to investigate the antitumor effects of the novel pt η1 c2h4ome dmso phen phen 1 10 phenanthroline compound on neuroblastoma cancer cells
url http://dx.doi.org/10.1155/2022/8932137
work_keys_str_mv AT federicadecastro anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT erikastefano anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT erikdeluca anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT antonellamuscella anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT santomarsigliante anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT michelebenedetti anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT francescopaolofanizzi anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT federicadecastro nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT erikastefano nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT erikdeluca nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT antonellamuscella nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT santomarsigliante nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT michelebenedetti nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells
AT francescopaolofanizzi nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells